老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Annovis Bio, Inc.

1.55
-0.0474-2.96%
成交量：11.31萬
成交額：18.41萬
市值：3,025.43萬
市盈率：-0.67
高：1.74
開：1.62
低：1.51
收：1.60
資料載入中...
總覽公司新聞資訊公告
2021/03/03

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/09

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/09

重要事件披露

8-K - Current report
2020/06/05

重要事件披露

8-K - Current report
2020/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/20

超過5%披露

General statement of acquisition of beneficial ownership
2020/04/03

重要事件披露

Current report, item 8.01
2020/03/25

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/06

重要事件披露

Current report, items 5.03 and 9.01
2020/01/30

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/24

SEC問詢函

[Cover]Correspondence
2020/01/24

SEC問詢函

[Cover]Correspondence
2020/01/24

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/21

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
更多